Decision-making about breast cancer susceptibility testing: How similar are the attitudes of physicians, nurse practitioners, and at-risk women?

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2868-2876

  Geller, Gail ^a   Bernhardt, Barbara A ^b   Doksum, Teresa ^b   Helzlsouer, Kathy J ^b   Wilcox, Patti ^b   Holtzman, Neil A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; DEPRESSION; FEMALE; GENE MUTATION; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DECISION MAKING; NURSE ATTITUDE; PATIENT COUNSELING; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031879453     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2868     Document Type: Article

References (38)

1. Kahn P: Coming to grips with genes and risk. Science 274:496-498, 1996
2. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997
3. National Advisory Council for Human Genome Research: Statement on the use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785, 1994
4. American Society of Human Genetics: Statement of the American Society of Human Genetics on Genetic Testing for Breast and Ovarian Cancer Predisposition. Am J Hum Genet 55:i-iv, 1994
5. National Breast Cancer Coalition: Presymptomatic Genetic Testing for Heritable Breast Cancer Risk. Washington, DC, National Breast Cancer Coalition, 1995
6. National Action Plan on Breast Cancer: Commentary on the ASCO statement on genetic testing for cancer susceptibility. J Clin Oncol 14:1738-1740, 1996
7. Geller G, Holtzman NA: Implications of the human genome initiative for the primary care physician. Bioethics 5:318-325, 1991
8. Geller G, Tambor ES, Chase GA, et al: Incorporation of genetics into primary care practice: Will physicians do the counseling and will they be directive? Arch Fam Med 2:1119-1125, 1993
9. Myers MF, Doksum T, Holtzman NA: Coverage and provision of genetic services: Surveys of health maintenance organizations and academic genetic units. Am J Hum Genet 61:A56, 1997 (abstr 302)
10. Taylor KM, Keiner MJ: The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer. Can Med Assoc J 154:1155-1158, 1996
11. Myers MF, Bernhardt BA, Tambor ES, et al: Involving consumers in the development of an educational program for cystic fibrosis carrier screening. Am J Hum Genet 54:719-726, 1994
12. Allman RM, Yoels WC, Clair JM: Reconciling the agendas of physicians and patients, in Clair JM, Allman RM (eds): Sociomedical Perspectives on Patient Care. Lexington, KY, University Press of Kentucky, 1993, p 33
13. Geller G, Botkin J, Green M, et al: Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 277:1467-1474, 1997
14. James CA, Bernhardt BA, Doksum T, et al: Attitudes toward BRCA1 testing among physicians and medical students. Am J Hum Genet 59:A7, 1996 (abstr 25)
15. Rowley PT, Loader S: Attitudes of obstetrician-gynecologists toward DNA testing for a genetic susceptibility to breast cancer. Obstet Gynecol 88:611-615, 1996
16. Brown SA, Grimes DE: A meta-analysis of nurse practitioners and nurse midwives in primary care. Nurs Res 44:332-339, 1995
17. Brennan LA Jr, Krishan I, Nobrega FT, et al: The Mayo three-community hypertension control program: Outcome in a community-based hypertension clinic. Mayo Clin Proc 54:307-312, 1979
18. Zahnd EG, Coates TJ, Richard RJ, et al: Counseling medical patients about cigarette smoking: A comparison of the impact of training on nurse practitioners and physicians. Nurse Pract 15:10-13, 1990
19. Campbell JD, Mauksch HO, Heikirk HJ, et al: Collaborative practice and provider styles of delivering health care. Soc Sci Med 30:1359-1365, 1990
20. Avorn J, Everitt DE, Baker MW: The neglected medical history and therapeutic choices for abdominal pain: A nationwide study of 799 physicians and nurses. Arch Inter Med 151:694-698, 1991
21. Burman ME: Childhood primary care services in Wyoming. J Am Acad Nurse Pract 8:61-67, 1996
22. Geller G, Strauss M, Bernhardt BA, et al: "Altering the code" of informed consent: Insights from women regarding genetic testing for breast cancer susceptibility. Hastings Center Rep 27:28-33, 1997
23. Bernhardt BA, Geller G, Strauss M, et al: Towards a model informed consent process: A qualitative assessment of women's attitudes about genetic testing for breast cancer risk. J Genet Couns 6:207-222, 1997
24. Chan ECY, Sulmasy DP: What should men know about prostate specific antigen screening before giving informed consent? J Gen Intern Med 11S:114, 1996 (abstr)
25. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275:1885-1892, 1996
26. Audrain J, Rimer B, Cella D, et al: Genetic counseling and testing for breast-ovarian cancer susceptibility: What do women want? J Clin Oncol 16:133-138, 1998
27. ASHG/ACMG Report: Points to consider: Ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241, 1995
28. Ende J, Kazis L, Ash A: Measuring patients' desire for autonomy: Decision-making and information-seeking preferences among medical patients. J Gen Intern Med 4:23-29, 1989
29. Houn F, Helzlsouer K, Friedman NB: Practice of prophylactic mastectomy: A survey of Maryland surgeons. Am J Pub Health 85:801-805, 1995
30. Hartmann, et al: Prophylactic mastectomy: Preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 38:168, 1997 (abstr)
31. Schrag D, Kuntz KM, Garber JE, et al: Decision analysis -Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336:1465-1471, 1997
32. Stefanek M, Helzlsouer K, Wilcox P, et al: Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 24:412-419, 1995
33. American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736, 1996
34. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: BRCA1 and BRCA2. JAMA 277:997-1003, 1997
35. Katz J: Acknowledging Uncertainty: The Confrontation of Knowledge and Ignorance, in the Silent World of Doctor and Patient. New York, NY, Free Press, 1984, pp 165-206
36. Berry DL, Dodd MJ, Hinds PS, et al: Informed consent: Process and clinical issues. Oncol Nurs Forum 23:507-512, 1996
37. Dontje KJ, Sparks BT, Given BA: Establishing a collaborative practice in a comprehensive breast clinic. Clin Nurse Spec 10:95-101, 1996
38. Tessaro IA, Herman CJ, Shaw JE, et al: Cancer prevention knowledge, attitudes, and clinical practice of nurse practitioners in local public health departments in North Carolina. Cancer Nurs 19:269-274, 1996